TENOFOVIR DISOPROXIL FUMARATE

TENOFOVIR DISOPROXIL FUMARATE was reported 45432 times

TENOFOVIR DISOPROXIL FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SKELETAL INJURY 8338 0.8054
1 AIDS CHOLANGIOPATHY 9 0.7500
2 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 86 0.6667
3 CSF HIV VIRUS IDENTIFIED 14 0.6087
4 PERINATAL HBV INFECTION 10 0.5882
5 CSF VIRUS IDENTIFIED 35 0.5000
6 BONE LOSS 7084 0.4708
7 TOOTH INJURY 2019 0.4646
8 MULTIPLE FRACTURES 6842 0.4161
9 ULTRASOUND ANTENATAL SCREEN 36 0.3750
10 PROTEIN TOTAL ABNORMAL 446 0.3425
11 BONE DENSITY DECREASED 10696 0.3410
12 FANCONI SYNDROME ACQUIRED 578 0.3290
13 RENAL INJURY 9285 0.3123
14 HIV VIRAEMIA 65 0.3095
15 BONE DEMINERALISATION 292 0.2757
16 MITOCHONDRIAL TOXICITY 203 0.2473
17 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 9 0.2432
18 AIDS ENCEPHALOPATHY 13 0.2241
19 OSTEONECROSIS 7271 0.2212
20 TOOTH LOSS 4538 0.2187
21 HEPATITIS D 17 0.2024
22 VIRAL MUTATION IDENTIFIED 736 0.1996
23 RENAL TUBULAR DYSFUNCTION 110 0.1947
24 HEPATITIS B DNA INCREASED 128 0.1899
25 HEPATITIS B DNA ASSAY POSITIVE 24 0.1875
26 HEMIVERTEBRA 31 0.1834
27 OSTEOMALACIA 251 0.1624
28 VIROLOGIC FAILURE 836 0.1553
29 AIDS RELATED COMPLICATION 10 0.1538
30 OSTEOPENIA 2270 0.1494
31 HYPOPHOSPHATAEMIC OSTEOMALACIA 39 0.1477
32 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 49 0.1463
33 GLOMERULAR FILTRATION RATE ABNORMAL 204 0.1440
34 GENOTYPE DRUG RESISTANCE TEST POSITIVE 137 0.1333
35 BETA 2 MICROGLOBULIN URINE INCREASED 19 0.1329
36 OSTEOPOROSIS 5420 0.1316
37 CSF HIV ESCAPE SYNDROME 18 0.1304
38 LIPODYSTROPHY ACQUIRED 276 0.1299
39 FANCONI SYNDROME 181 0.1279
40 CHRONIC HEPATITIS B 37 0.1167
41 BIRTH MARK 24 0.1154
42 NEPHROPATHY 1069 0.1144
43 BLOOD HIV RNA INCREASED 195 0.1074
44 HYPERPHOSPHATURIA 12 0.1026
45 DEGENERATIVE BONE DISEASE 45 0.1016
46 CHRONIC KIDNEY DISEASE 7310 0.0961
47 ANHEDONIA 2459 0.0935
48 URINE PHOSPHORUS INCREASED 10 0.0917
49 CONGENITAL UMBILICAL HERNIA 34 0.0912
50 IMMUNE RECONSTITUTION SYNDROME 117 0.0906
51 GLYCOSURIA 122 0.0902
52 PATHOGEN RESISTANCE 802 0.0879
53 BONE DENSITY ABNORMAL 314 0.0839
54 VIRAL LOAD DECREASED 12 0.0822
55 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 22 0.0791
56 RENAL TUBULAR DISORDER 215 0.0763
57 ADRENOGENITAL SYNDROME 10 0.0741
58 ACQUIRED IMMUNODEFICIENCY SYNDROME 38 0.0732
59 BRACHYDACTYLY 14 0.0711
60 THYMUS ENLARGEMENT 11 0.0688
61 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 339 0.0680
62 ARTHRODESIS 69 0.0678
63 BONE METABOLISM DISORDER 20 0.0664
64 TRISOMY 18 24 0.0630
65 ECONOMIC PROBLEM 905 0.0597
66 ULTRASOUND ANTENATAL SCREEN ABNORMAL 13 0.0591
67 VIRAL LOAD INCREASED 224 0.0576
68 MENINGOMYELOCELE 34 0.0567
69 CONGENITAL CHOROID PLEXUS CYST 17 0.0557
70 ACQUIRED GENE MUTATION 73 0.0557
71 RENAL TUBULAR ACIDOSIS 119 0.0545
72 HYDROPS FOETALIS 33 0.0538
73 DEXTROCARDIA 10 0.0535
74 MITOCHONDRIAL CYTOPATHY 23 0.0523
75 VITAMIN D DEFICIENCY 507 0.0519
76 HEPATITIS B 312 0.0517
77 BRAIN STEM STROKE 25 0.0507
78 RENAL FAILURE 6700 0.0504
79 HYPOURICAEMIA 14 0.0483
80 TEETH BRITTLE 50 0.0478
81 HIV TEST POSITIVE 31 0.0469
82 PSYCHIATRIC DECOMPENSATION 86 0.0440
83 HEPATITIS B REACTIVATION 138 0.0434
84 CONGENITAL HYDROCEPHALUS 22 0.0434
85 OPHTHALMOPLEGIA 67 0.0424
86 FRACTURE 803 0.0424
87 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 45 0.0424
88 MICROGNATHIA 21 0.0420
89 RENAL ANEURYSM 10 0.0417
90 CONGENITAL SKIN DIMPLES 10 0.0415
91 GENE MUTATION IDENTIFICATION TEST POSITIVE 17 0.0404
92 SPINE MALFORMATION 14 0.0403
93 OSTEOPOROTIC FRACTURE 76 0.0397
94 KAPOSI'S SARCOMA 19 0.0378
95 PLACENTAL INSUFFICIENCY 30 0.0374
96 CD4 LYMPHOCYTES DECREASED 80 0.0373
97 HEPATITIS B SURFACE ANTIGEN POSITIVE 10 0.0365
98 ACUTE HIV INFECTION 9 0.0364
99 MACROCEPHALY 14 0.0361
100 EXTRAOCULAR MUSCLE PARESIS 16 0.0349
101 HYPOPHOSPHATAEMIA 254 0.0343
102 ACUTE HEPATITIS B 11 0.0331
103 LARYNGOMALACIA 11 0.0328
104 PSYCHOMOTOR SKILLS IMPAIRED 85 0.0324
105 ANKYLOGLOSSIA CONGENITAL 13 0.0323
106 BLOOD PHOSPHORUS DECREASED 117 0.0320
107 STILLBIRTH 154 0.0318
108 END STAGE RENAL DISEASE 579 0.0317
109 LIPOATROPHY 29 0.0305
110 CLEFT LIP AND PALATE 34 0.0304
111 CUSHING'S SYNDROME 21 0.0302
112 BENIGN HYDATIDIFORM MOLE 10 0.0302
113 HAND FRACTURE 214 0.0302
114 MULTIPLE-DRUG RESISTANCE 91 0.0293
115 ALLERGIC OEDEMA 19 0.0293
116 HIV INFECTION 88 0.0292
117 DRUG RESISTANCE 745 0.0290
118 PORTAL HYPERTENSIVE GASTROPATHY 16 0.0284
119 CHOLESTASIS OF PREGNANCY 13 0.0283
120 GASTRIC VARICES 13 0.0276
121 DIAPHRAGMATIC HERNIA 17 0.0274
122 TOOTH FRACTURE 292 0.0265
123 NEPHROPATHY TOXIC 297 0.0264
124 BONE DISORDER 480 0.0263
125 PROTEIN TOTAL INCREASED 70 0.0263
126 TRISOMY 21 33 0.0262
127 POLYDACTYLY 30 0.0259
128 OESOPHAGEAL ATRESIA 16 0.0256
129 CONGENITAL DIAPHRAGMATIC HERNIA 10 0.0256
130 BLOOD PHOSPHORUS ABNORMAL 12 0.0255
131 PORPHYRIA NON-ACUTE 11 0.0253
132 ALPHA 1 FOETOPROTEIN INCREASED 18 0.0253
133 BLOOD CREATININE INCREASED 1635 0.0250
134 DEPRESSIVE SYMPTOM 88 0.0249
135 DEPRESSION SUICIDAL 86 0.0248
136 PLACENTAL DISORDER 23 0.0243
137 ALBUMINURIA 13 0.0243
138 EMOTIONAL DISTRESS 2861 0.0236
139 NEURAL TUBE DEFECT 17 0.0234
140 SKULL MALFORMATION 15 0.0233
141 FOOT FRACTURE 441 0.0232
142 CRYPTORCHISM 26 0.0232
143 MICROALBUMINURIA 17 0.0225
144 SYPHILIS 16 0.0220
145 NODULAR REGENERATIVE HYPERPLASIA 14 0.0218
146 CYTOMEGALOVIRUS CHORIORETINITIS 42 0.0215
147 FOREARM FRACTURE 15 0.0215
148 SCAPULA FRACTURE 11 0.0211
149 PROTEINURIA 400 0.0210
150 TEARFULNESS 90 0.0209
151 NEPHROGENIC DIABETES INSIPIDUS 24 0.0208
152 HYDROCELE 22 0.0206
153 VARICES OESOPHAGEAL 62 0.0205
154 PORTAL HYPERTENSION 63 0.0204
155 PROTEIN URINE PRESENT 100 0.0200
156 RENAL ATROPHY 25 0.0200
157 VOLVULUS 46 0.0194
158 SHOULDER ARTHROPLASTY 52 0.0193
159 GENE MUTATION 38 0.0192
160 ARNOLD-CHIARI MALFORMATION 18 0.0189
161 BLOOD LACTIC ACID INCREASED 98 0.0186
162 ANKLE FRACTURE 287 0.0185
163 WRIST FRACTURE 220 0.0183
164 EYELID PTOSIS 186 0.0183
165 CEREBRAL TOXOPLASMOSIS 17 0.0182
166 RENAL IMPAIRMENT 1527 0.0182
167 TIBIA FRACTURE 85 0.0181
168 DEATH NEONATAL 25 0.0180
169 BLOOD BILIRUBIN UNCONJUGATED INCREASED 13 0.0179
170 HEPATITIS A 15 0.0177
171 HYPERPARATHYROIDISM SECONDARY 44 0.0175
172 NEPHRITIS INTERSTITIAL 22 0.0174
173 VIRAEMIA 24 0.0173
174 NECROTISING RETINITIS 11 0.0172
175 BLOOD CREATININE ABNORMAL 59 0.0170
176 MALARIA 12 0.0170
177 FIBULA FRACTURE 49 0.0170
178 LYMPHOCYTIC INFILTRATION 17 0.0169
179 HYPERPHOSPHATAEMIA 36 0.0167
180 ANAEMIA OF CHRONIC DISEASE 15 0.0166
181 RETINAL TOXICITY 17 0.0165
182 LIPOHYPERTROPHY 10 0.0161
183 RENAL COLIC 36 0.0159
184 JAW FRACTURE 34 0.0157
185 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 20 0.0156
186 LIVER TRANSPLANT 56 0.0154
187 BLOOD BICARBONATE DECREASED 29 0.0153
188 VANISHING BILE DUCT SYNDROME 17 0.0152
189 HODGKIN'S DISEASE 11 0.0152
190 BONE DEFORMITY 10 0.0149
191 RENAL TUBULAR NECROSIS 146 0.0149
192 ABDOMINAL SEPSIS 13 0.0148
193 PROTEIN URINE 13 0.0144
194 BLOOD CREATINE INCREASED 63 0.0142
195 INTERVERTEBRAL DISC DEGENERATION 131 0.0141
196 GLOMERULAR FILTRATION RATE DECREASED 173 0.0141
197 PLACENTA PRAEVIA 11 0.0140
198 RENAL TUBULAR INJURY 17 0.0140
199 SUPERINFECTION BACTERIAL 11 0.0139
200 VISCERAL LEISHMANIASIS 10 0.0139
201 MENINGITIS CRYPTOCOCCAL 24 0.0137
202 INTRA-UTERINE DEATH 22 0.0137
203 CLAVICLE FRACTURE 52 0.0136
204 HEPATOCELLULAR CARCINOMA 103 0.0135
205 RIB FRACTURE 277 0.0135
206 RADIUS FRACTURE 32 0.0133
207 TWIN PREGNANCY 11 0.0131
208 ADRENAL SUPPRESSION 11 0.0130
209 PNEUMOCYSTIS JIROVECI PNEUMONIA 29 0.0130
210 RENAL TRANSPLANT 47 0.0130
211 PATHOLOGICAL FRACTURE 65 0.0128
212 CREATININE RENAL CLEARANCE DECREASED 50 0.0125
213 ANAL CANCER 12 0.0124
214 SHOULDER FRACTURE 20 0.0122
215 VERTEBRAL FORAMINAL STENOSIS 10 0.0121
216 OSTEOCHONDROSIS 14 0.0121
217 CYTOLYTIC HEPATITIS 40 0.0120
218 HEPATORENAL SYNDROME 20 0.0118
219 HYPERPARATHYROIDISM 24 0.0116
220 FOETAL EXPOSURE DURING PREGNANCY 942 0.0116
221 SPINA BIFIDA 24 0.0115
222 OESOPHAGEAL VARICES HAEMORRHAGE 25 0.0115
223 RENAL CYST 91 0.0114
224 ABORTION SPONTANEOUS 458 0.0114
225 ANAEMIA MACROCYTIC 24 0.0112
226 ANOGENITAL WARTS 10 0.0112
227 PREMATURE RUPTURE OF MEMBRANES 27 0.0112
228 FOETAL GROWTH RESTRICTION 68 0.0112
229 ULNA FRACTURE 11 0.0111
230 HEPATIC FIBROSIS 38 0.0111
231 MUCOSAL EROSION 10 0.0110
232 LIVE BIRTH 92 0.0110
233 NEPHROCALCINOSIS 13 0.0110
234 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 12 0.0109
235 HEPATIC CIRRHOSIS 205 0.0109
236 FACIAL BONES FRACTURE 39 0.0108
237 HYPERLACTACIDAEMIA 29 0.0108
238 DENTAL CARIES 119 0.0107
239 SPINAL STENOSIS 44 0.0106
240 VENTRICULAR SEPTAL DEFECT 61 0.0106
241 CONGENITAL ANOMALY 80 0.0103
242 HYPERTENSIVE NEPHROPATHY 11 0.0103
243 CAESAREAN SECTION 120 0.0103
244 DECREASED ACTIVITY 111 0.0103
245 ABORTION INDUCED 96 0.0102
246 HIP ARTHROPLASTY 156 0.0102
247 BLOOD AMYLASE INCREASED 17 0.0099
248 QUALITY OF LIFE DECREASED 133 0.0099
249 PATELLA FRACTURE 23 0.0098
250 DYSLIPIDAEMIA 50 0.0098
251 POLYHYDRAMNIOS 10 0.0098
252 OESOPHAGEAL CANDIDIASIS 39 0.0098
253 MYCOBACTERIUM AVIUM COMPLEX INFECTION 26 0.0097
254 NEONATAL RESPIRATORY DISTRESS SYNDROME 34 0.0096
255 PULMONARY TUBERCULOSIS 41 0.0096
256 GLUCOSE URINE PRESENT 12 0.0094
257 FOETAL DISTRESS SYNDROME 20 0.0094
258 BILIRUBIN CONJUGATED INCREASED 22 0.0094
259 ANXIETY 2677 0.0094
260 HUMERUS FRACTURE 45 0.0093
261 BONE MARROW TOXICITY 11 0.0093
262 METABOLIC SYNDROME 15 0.0091
263 ENCEPHALITIS VIRAL 11 0.0090
264 SPINAL COMPRESSION FRACTURE 74 0.0089
265 FRACTURED SACRUM 11 0.0088
266 PREMATURE LABOUR 50 0.0088
267 FEMORAL NECK FRACTURE 45 0.0088
268 HEPATITIS FULMINANT 26 0.0088
269 NECROTISING COLITIS 11 0.0087
270 SPINAL OSTEOARTHRITIS 76 0.0086
271 KIDNEY FIBROSIS 15 0.0086
272 CALCULUS URINARY 13 0.0084
273 HYPERBILIRUBINAEMIA 87 0.0084
274 PREGNANCY 168 0.0084
275 RENAL INFARCT 12 0.0083
276 HEPATOSPLENOMEGALY 21 0.0082
277 GLOMERULONEPHRITIS 20 0.0082
278 PNEUMONIA PNEUMOCOCCAL 12 0.0081
279 SPONDYLOLISTHESIS 14 0.0081
280 LOWER LIMB FRACTURE 155 0.0081
281 SMALL FOR DATES BABY 40 0.0080
282 LOW BIRTH WEIGHT BABY 64 0.0080
283 ACUTE KIDNEY INJURY 1224 0.0080
284 NEPHROGENIC ANAEMIA 37 0.0080
285 MATERNAL DRUGS AFFECTING FOETUS 61 0.0079
286 PREMATURE DELIVERY 126 0.0079
287 FRACTURED COCCYX 10 0.0079
288 ATYPICAL MYCOBACTERIAL INFECTION 11 0.0078
289 PORTAL VEIN THROMBOSIS 25 0.0077
290 INTERMITTENT CLAUDICATION 12 0.0076
291 OLIGOHYDRAMNIOS 25 0.0075
292 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 12 0.0075
293 PREMATURE BABY 225 0.0075
294 DISSEMINATED TUBERCULOSIS 19 0.0074
295 OCULAR ICTERUS 32 0.0074
296 RENAL FAILURE ACUTE 313 0.0074
297 CEREBELLAR SYNDROME 16 0.0073
298 LIMB OPERATION 35 0.0073
299 DRUG EXPOSURE DURING PREGNANCY 245 0.0072
300 HIP FRACTURE 231 0.0072
301 OSTEOARTHRITIS 303 0.0071
302 UPPER LIMB FRACTURE 142 0.0071
303 ABORTION MISSED 9 0.0071
304 DIABETES INSIPIDUS 17 0.0071
305 DIPLOPIA 183 0.0070
306 HEPATIC FAILURE 212 0.0070
307 CACHEXIA 36 0.0070
308 STRESS FRACTURE 37 0.0069
309 HYPERTRIGLYCERIDAEMIA 40 0.0068
310 GENERALISED ANXIETY DISORDER 10 0.0068
311 LUMBAR VERTEBRAL FRACTURE 31 0.0068
312 TALIPES 21 0.0068
313 THORACIC VERTEBRAL FRACTURE 20 0.0068
314 CERVICAL VERTEBRAL FRACTURE 23 0.0067
315 UNDERWEIGHT 13 0.0066
316 HYDRONEPHROSIS 49 0.0065
317 PREMATURE SEPARATION OF PLACENTA 10 0.0065
318 MATERNAL EXPOSURE DURING PREGNANCY 570 0.0064
319 SPINAL FRACTURE 128 0.0064
320 NEONATAL DISORDER 10 0.0063
321 RENAL MASS 13 0.0063
322 BLOOD PHOSPHORUS INCREASED 17 0.0062
323 CHRONIC GASTRITIS 14 0.0062
324 ECTOPIC PREGNANCY 19 0.0062
325 FOETAL DEATH 32 0.0062
326 COMPRESSION FRACTURE 33 0.0062
327 CRYPTOCOCCOSIS 10 0.0061
328 PSYCHOMOTOR RETARDATION 17 0.0060
329 IGA NEPHROPATHY 10 0.0060
330 HEPATITIS C 72 0.0060
331 ALANINE AMINOTRANSFERASE INCREASED 362 0.0059
332 HEPATIC ENCEPHALOPATHY 55 0.0059
333 LUMBAR SPINAL STENOSIS 17 0.0058
334 HEPATIC CYTOLYSIS 74 0.0058
335 NEPHROLITHIASIS 265 0.0058
336 LACTIC ACIDOSIS 187 0.0058
337 HYPOSPADIAS 12 0.0058
338 ALANINE AMINOTRANSFERASE ABNORMAL 12 0.0057
339 HEPATIC NEOPLASM MALIGNANT 12 0.0057
340 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 18 0.0055
341 FIBROSIS 17 0.0055
342 LEFT VENTRICULAR FAILURE 19 0.0055
343 NEUROLOGICAL SYMPTOM 31 0.0054
344 POLYURIA 44 0.0054
345 POLYDIPSIA 21 0.0053
346 PARANOIA 91 0.0053
347 ATRIAL SEPTAL DEFECT 44 0.0052
348 HEPATIC MASS 10 0.0052
349 EXPOSURE DURING PREGNANCY 322 0.0052
350 JAUNDICE 139 0.0052
351 BLOOD BILIRUBIN INCREASED 138 0.0051
352 NEPHROTIC SYNDROME 35 0.0051
353 RENAL FAILURE CHRONIC 39 0.0051
354 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 242 0.0050
355 ASPARTATE AMINOTRANSFERASE INCREASED 267 0.0050
356 HEPATITIS TOXIC 13 0.0050
357 TREATMENT NONCOMPLIANCE 272 0.0050
358 RENAL FUNCTION TEST ABNORMAL 23 0.0049
359 PAIN 3040 0.0049
360 SPINAL COLUMN INJURY 11 0.0049
361 HEPATIC STEATOSIS 91 0.0049
362 HEPATOMEGALY 48 0.0049
363 PELVIC FRACTURE 38 0.0049
364 ILEUS PARALYTIC 21 0.0047
365 BLOOD ALKALINE PHOSPHATASE INCREASED 116 0.0047
366 DYSMORPHISM 11 0.0047
367 HEPATITIS 119 0.0046
368 METABOLIC ACIDOSIS 148 0.0046
369 DERMATITIS EXFOLIATIVE 23 0.0046
370 DIALYSIS 65 0.0046
371 HEART DISEASE CONGENITAL 16 0.0045
372 EXERCISE TOLERANCE DECREASED 26 0.0045
373 BLOOD CREATINE PHOSPHOKINASE INCREASED 130 0.0045
374 HEPATIC NECROSIS 17 0.0045
375 NEPHRITIS 15 0.0045
376 ACIDOSIS 34 0.0044
377 HYPERURICAEMIA 18 0.0044
378 APLASIA PURE RED CELL 15 0.0044
379 EXPOSURE VIA BREAST MILK 17 0.0043
380 REBOUND EFFECT 48 0.0042
381 SPLENOMEGALY 49 0.0042
382 ABDOMINAL HERNIA 19 0.0042
383 HEPATITIS CHOLESTATIC 25 0.0041
384 DRUG-INDUCED LIVER INJURY 130 0.0041
385 RENAL DISORDER 189 0.0041
386 CUSHINGOID 13 0.0040
387 LIPASE INCREASED 31 0.0040
388 TREATMENT FAILURE 335 0.0040
389 TUBULOINTERSTITIAL NEPHRITIS 75 0.0040
390 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 33 0.0040
391 FEMUR FRACTURE 123 0.0040
392 NECROSIS 22 0.0039
393 HAEMOLYTIC ANAEMIA 35 0.0039
394 PSYCHOTIC DISORDER 115 0.0039
395 AUTOIMMUNE HEPATITIS 27 0.0039
396 ASCITES 114 0.0039
397 HYDROCEPHALUS 21 0.0039
398 STAPHYLOCOCCAL SEPSIS 19 0.0038
399 LIP OEDEMA 16 0.0038
400 RENAL PAIN 40 0.0038
401 ENCEPHALITIS 26 0.0038
402 AZOTAEMIA 15 0.0038
403 HEPATIC CANCER 90 0.0037
404 ANOREXIA 48 0.0037
405 SPINAL FUSION SURGERY 15 0.0037
406 HAEMODIALYSIS 31 0.0037
407 THROMBOTIC THROMBOCYTOPENIC PURPURA 13 0.0037
408 NORMAL NEWBORN 20 0.0037
409 HEPATIC NEOPLASM 12 0.0037
410 UMBILICAL HERNIA 17 0.0036
411 DRUG LEVEL BELOW THERAPEUTIC 20 0.0036
412 BONE PAIN 210 0.0036
413 CARDIAC MURMUR 31 0.0036
414 GESTATIONAL DIABETES 17 0.0036
415 TOOTH EXTRACTION 44 0.0035
416 CEREBRAL ATROPHY 14 0.0035
417 DIFFUSE LARGE B-CELL LYMPHOMA 27 0.0035
418 CANDIDIASIS 14 0.0035
419 GAMMA-GLUTAMYLTRANSFERASE INCREASED 77 0.0035
420 PNEUMOCYSTIS JIROVECII PNEUMONIA 34 0.0034
421 GLUCOSE TOLERANCE IMPAIRED 20 0.0034
422 HISTIOCYTOSIS HAEMATOPHAGIC 10 0.0034
423 HEPATIC FUNCTION ABNORMAL 124 0.0033
424 TRANSAMINASES INCREASED 73 0.0033
425 BLOOD ALBUMIN DECREASED 26 0.0033
426 HYPOVOLAEMIA 19 0.0032
427 DRUG INTERACTION 510 0.0032
428 CONTRAINDICATED PRODUCT ADMINISTERED 96 0.0032
429 LYMPHOMA 49 0.0032
430 DYSSTASIA 92 0.0031
431 HEPATOTOXICITY 69 0.0031
432 ABORTION 9 0.0031
433 FACET JOINT SYNDROME 10 0.0031
434 HEPATIC PAIN 13 0.0030
435 NYSTAGMUS 16 0.0030
436 EXTRASYSTOLES 21 0.0030
437 POST-TRAUMATIC STRESS DISORDER 20 0.0030
438 RASH MACULO-PAPULAR 66 0.0030
439 BLOOD TRIGLYCERIDES INCREASED 52 0.0029
440 SKIN HYPERPIGMENTATION 25 0.0029
441 LIVER INJURY 71 0.0029
442 ORAL CANDIDIASIS 38 0.0029
443 MALABSORPTION 15 0.0029
444 LIVER DISORDER 127 0.0029
445 CAROTID ARTERY STENOSIS 10 0.0029
446 HYPERLIPIDAEMIA 34 0.0028
447 BLOOD LACTATE DEHYDROGENASE INCREASED 45 0.0028
448 HAND DEFORMITY 37 0.0028
449 HYPERPHAGIA 11 0.0028
450 HYPOKALAEMIA 127 0.0027
451 LYMPHOEDEMA 19 0.0027
452 BLOOD UREA INCREASED 46 0.0027
453 PRE-ECLAMPSIA 13 0.0027
454 LYMPHADENOPATHY 96 0.0027
455 INTERVERTEBRAL DISC PROTRUSION 59 0.0027
456 EUGLYCAEMIC DIABETIC KETOACIDOSIS 11 0.0027
457 RENAL CELL CARCINOMA 13 0.0027
458 ANAEMIA 506 0.0027
459 B-CELL LYMPHOMA 9 0.0026
460 PANCREATIC DISORDER 13 0.0026
461 ISCHAEMIA 12 0.0026
462 MULTI-ORGAN FAILURE 45 0.0026
463 POLYNEUROPATHY 31 0.0026
464 PANCREATITIS ACUTE 58 0.0026
465 BLOOD CALCIUM DECREASED 29 0.0026
466 INTERVERTEBRAL DISC DISORDER 11 0.0026
467 MYOSITIS 23 0.0026
468 YELLOW SKIN 12 0.0026
469 SKIN LESION 70 0.0025
470 RHABDOMYOLYSIS 105 0.0025
471 CHOLESTASIS 48 0.0025
472 TRANSPLANT REJECTION 20 0.0025
473 HYPERCHOLESTEROLAEMIA 24 0.0025
474 HEPATOCELLULAR INJURY 35 0.0025
475 HYPOCALCAEMIA 46 0.0024
476 PYELONEPHRITIS 21 0.0024
477 DRUG TOXICITY 33 0.0024
478 CHOLANGITIS 15 0.0024
479 ACUTE HEPATIC FAILURE 33 0.0024
480 EXOSTOSIS 22 0.0024
481 HIP SURGERY 13 0.0024
482 HAEMATURIA 81 0.0024
483 INTESTINAL ISCHAEMIA 13 0.0024
484 VITAMIN D DECREASED 20 0.0023
485 IMPAIRED WORK ABILITY 50 0.0023
486 DEPRESSION 530 0.0023
487 EYELID OEDEMA 27 0.0023
488 HEPATIC LESION 10 0.0023
489 STEVENS-JOHNSON SYNDROME 51 0.0023
490 TOXIC SKIN ERUPTION 23 0.0023
491 GUILLAIN-BARRE SYNDROME 11 0.0023
492 LIVER FUNCTION TEST ABNORMAL 66 0.0023
493 ARTERIOSCLEROSIS CORONARY ARTERY 15 0.0023
494 PHARYNGOLARYNGEAL PAIN 12 0.0023
495 SOCIAL AVOIDANT BEHAVIOUR 13 0.0022
496 PANCYTOPENIA 125 0.0022
497 ADRENAL INSUFFICIENCY 27 0.0022
498 TACHYPNOEA 30 0.0022
499 HYPOALBUMINAEMIA 17 0.0022
500 DRUG TOLERANCE 11 0.0022
501 ANGINA UNSTABLE 14 0.0022
502 LUNG INFILTRATION 19 0.0021
503 HYPERKALAEMIA 75 0.0021
504 MOBILITY DECREASED 153 0.0021
505 LOW DENSITY LIPOPROTEIN INCREASED 16 0.0021
506 RALES 12 0.0021
507 GASTROENTERITIS 30 0.0021
508 NERVOUS SYSTEM DISORDER 63 0.0020
509 DRUG LEVEL INCREASED 33 0.0020
510 VULVOVAGINAL PRURITUS 10 0.0020
511 DYSPHAGIA 186 0.0020
512 CARDIOMEGALY 24 0.0019
513 CHROMATURIA 44 0.0019
514 ATRIOVENTRICULAR BLOCK COMPLETE 13 0.0019
515 SCOLIOSIS 12 0.0019
516 OLIGURIA 12 0.0019
517 PANCREATITIS 102 0.0019
518 APLASTIC ANAEMIA 10 0.0019
519 HERPES VIRUS INFECTION 11 0.0019
520 BLOOD URIC ACID INCREASED 11 0.0019
521 NEOPLASM PROGRESSION 66 0.0019
522 DIABETES MELLITUS 144 0.0019
523 MALNUTRITION 21 0.0019
524 ANURIA 16 0.0019
525 MYOPATHY 16 0.0019
526 CHOLECYSTITIS 22 0.0018
527 BRAIN OEDEMA 23 0.0018
528 MENINGITIS 12 0.0018
529 SPINAL DISORDER 17 0.0018
530 INTRACRANIAL PRESSURE INCREASED 10 0.0018
531 HAEMATOTOXICITY 17 0.0018
532 RHEUMATOID ARTHRITIS 203 0.0018
533 SKIN PLAQUE 15 0.0018
534 GENERALISED OEDEMA 22 0.0018
535 ABNORMAL LOSS OF WEIGHT 12 0.0018
536 EYE MOVEMENT DISORDER 12 0.0018
537 POLLAKIURIA 73 0.0017
538 CYTOMEGALOVIRUS INFECTION 29 0.0017
539 MUSCLE ATROPHY 22 0.0017
540 JOINT INJURY 37 0.0017
541 CORONARY ARTERY DISEASE 52 0.0017
542 EOSINOPHILIA 30 0.0017
543 ARTERIOSCLEROSIS 16 0.0017
544 SHOCK 39 0.0017
545 HEPATITIS ACUTE 11 0.0017
546 TOOTH DISORDER 37 0.0017
547 KNEE ARTHROPLASTY 35 0.0017
548 CHOLELITHIASIS 54 0.0016
549 PERICARDIAL EFFUSION 38 0.0016
550 VENTRICULAR EXTRASYSTOLES 17 0.0016
551 GASTRIC ULCER 31 0.0016
552 LIVER FUNCTION TEST INCREASED 35 0.0016
553 ENCEPHALOPATHY 40 0.0016
554 DRUG INTOLERANCE 156 0.0016
555 MATERNAL EXPOSURE BEFORE PREGNANCY 11 0.0016
556 SQUAMOUS CELL CARCINOMA 15 0.0016
557 HYPERTHYROIDISM 23 0.0016
558 MULTIPLE INJURIES 10 0.0016
559 DRUG ERUPTION 28 0.0016
560 KIDNEY INFECTION 31 0.0016
561 NEUROPATHY PERIPHERAL 150 0.0016
562 PHOTOSENSITIVITY REACTION 26 0.0016
563 DRUG LEVEL DECREASED 16 0.0016
564 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 40 0.0016
565 RASH GENERALISED 40 0.0015
566 TYPE 2 DIABETES MELLITUS 52 0.0015
567 FOOT DEFORMITY 17 0.0015
568 BRADYPHRENIA 10 0.0015
569 GASTRITIS 40 0.0015
570 WALKING AID USER 10 0.0015
571 DERMATITIS ALLERGIC 19 0.0015
572 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
573 OSTEOMYELITIS 27 0.0015
574 ABNORMAL DREAMS 41 0.0015
575 ERECTILE DYSFUNCTION 38 0.0015
576 IMMUNOSUPPRESSION 13 0.0015
577 SUICIDAL IDEATION 134 0.0015
578 ELECTROLYTE IMBALANCE 17 0.0015
579 AGRANULOCYTOSIS 27 0.0015
580 MASS 20 0.0014
581 DUODENAL ULCER 10 0.0014
582 GAIT DISTURBANCE 268 0.0014
583 PSEUDOMONAS INFECTION 12 0.0014
584 VISUAL FIELD DEFECT 10 0.0014
585 DERMATITIS BULLOUS 10 0.0014
586 PYREXIA 478 0.0014
587 HAEMATEMESIS 35 0.0014
588 HYPOKINESIA 20 0.0014
589 HYPERCALCAEMIA 17 0.0014
590 SPINAL PAIN 16 0.0014
591 FACE OEDEMA 23 0.0014
592 THROMBOCYTOPENIA 152 0.0014
593 BLOOD POTASSIUM INCREASED 22 0.0014
594 DISSEMINATED INTRAVASCULAR COAGULATION 19 0.0013
595 DYSURIA 49 0.0013
596 DEVELOPMENTAL DELAY 12 0.0013
597 STATUS EPILEPTICUS 15 0.0013
598 TOXIC EPIDERMAL NECROLYSIS 20 0.0013
599 SEPTIC SHOCK 57 0.0013
600 HYPOTONIA 13 0.0013
601 NEUROTOXICITY 22 0.0013
602 ACUTE MYOCARDIAL INFARCTION 37 0.0013
603 SCIATICA 20 0.0013
604 GENERAL PHYSICAL HEALTH DETERIORATION 145 0.0013
605 MYASTHENIA GRAVIS 10 0.0012
606 CIRCULATORY COLLAPSE 21 0.0012
607 JOINT DISLOCATION 13 0.0012
608 SUDDEN DEATH 13 0.0012
609 SHOCK HAEMORRHAGIC 10 0.0012
610 ASTHENIA 454 0.0012
611 ACUTE CORONARY SYNDROME 10 0.0012
612 COAGULOPATHY 20 0.0012
613 PNEUMONIA BACTERIAL 11 0.0012
614 RESPIRATORY DISTRESS 33 0.0012
615 DEPRESSED LEVEL OF CONSCIOUSNESS 47 0.0012
616 PARALYSIS 17 0.0012
617 ARTHROPATHY 66 0.0012
618 APPENDICITIS 11 0.0012
619 GOUT 21 0.0012
620 DEHYDRATION 155 0.0012
621 NO THERAPEUTIC RESPONSE 14 0.0011
622 HEPATIC ENZYME INCREASED 78 0.0011
623 CHOLECYSTECTOMY 13 0.0011
624 BONE MARROW FAILURE 23 0.0011
625 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
626 EATING DISORDER 24 0.0011
627 BACTERIAL INFECTION 21 0.0011
628 STAPHYLOCOCCAL INFECTION 37 0.0011
629 HYPERTENSION 237 0.0011
630 SUBDURAL HAEMATOMA 16 0.0011
631 THERAPY NON-RESPONDER 50 0.0011
632 LEUKOCYTOSIS 20 0.0011
633 BIPOLAR DISORDER 12 0.0011
634 OPTIC NEURITIS 10 0.0011
635 ATAXIA 13 0.0011
636 BACTERAEMIA 13 0.0011
637 WEIGHT DECREASED 305 0.0011
638 CENTRAL NERVOUS SYSTEM LESION 15 0.0011
639 PRESCRIBED OVERDOSE 21 0.0011
640 ABDOMINAL PAIN 252 0.0011
641 CARDIOMYOPATHY 16 0.0011
642 ABDOMINAL DISTENSION 113 0.0011
643 MOTOR DYSFUNCTION 11 0.0011
644 FEAR 29 0.0011
645 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
646 IMMUNODEFICIENCY 16 0.0011
647 ERYTHEMA MULTIFORME 10 0.0011
648 MYALGIA 181 0.0011
649 IMMUNE SYSTEM DISORDER 14 0.0011
650 ARTHRITIS 83 0.0011
651 BLOOD URINE PRESENT 20 0.0011
652 LABORATORY TEST ABNORMAL 31 0.0010
653 INTENTIONAL PRODUCT USE ISSUE 92 0.0010
654 COMA 50 0.0010
655 ILEUS 13 0.0010
656 JOINT RANGE OF MOTION DECREASED 14 0.0010
657 ABDOMINAL DISCOMFORT 175 0.0010
658 ATELECTASIS 10 0.0010
659 SEXUAL DYSFUNCTION 12 0.0010
660 HYPONATRAEMIA 57 0.0010
661 OESOPHAGEAL CARCINOMA 30 0.0010
662 NIGHTMARE 35 0.0010
663 NEUTROPENIA 137 0.0010
664 BACK PAIN 234 0.0010
665 PLATELET COUNT DECREASED 107 0.0010
666 HEMIPARESIS 17 0.0010
667 HAEMORRHAGE INTRACRANIAL 15 0.0010
668 LEUKOPENIA 50 0.0010
669 MELAENA 22 0.0010
670 TOOTHACHE 18 0.0010
671 VISUAL ACUITY REDUCED 33 0.0010
672 MULTIPLE ORGAN DYSFUNCTION SYNDROME 28 0.0010
673 MENTAL DISORDER 43 0.0010
674 HYPERGLYCAEMIA 36 0.0010
675 NEURALGIA 24 0.0010
676 SINUS TACHYCARDIA 14 0.0010
677 CEREBRAL HAEMORRHAGE 35 0.0010
678 SEPSIS 109 0.0010
679 PHARYNGITIS 12 0.0010
680 MYOCARDITIS 11 0.0010
681 BLOOD SODIUM DECREASED 18 0.0010
682 INFECTION 138 0.0010
683 MUSCULOSKELETAL DISORDER 18 0.0009
684 LUNG DISORDER 46 0.0009
685 RASH PAPULAR 21 0.0009
686 TREMOR 154 0.0009
687 DISEASE RECURRENCE 44 0.0009
688 CONDITION AGGRAVATED 281 0.0009
689 DEAFNESS 24 0.0009
690 VOMITING 428 0.0009
691 NOCTURIA 11 0.0009
692 RASH PRURITIC 49 0.0009
693 BLOOD CHOLESTEROL INCREASED 42 0.0009
694 NERVE INJURY 10 0.0009
695 MUSCULAR WEAKNESS 102 0.0009
696 THIRST 16 0.0009
697 CYST 11 0.0009
698 PNEUMOTHORAX 14 0.0009
699 GLAUCOMA 17 0.0009
700 DECREASED APPETITE 205 0.0009
701 POOR QUALITY SLEEP 19 0.0009
702 HYPOXIA 31 0.0009
703 OBESITY 14 0.0009
704 NIGHT SWEATS 28 0.0009
705 RASH 375 0.0009
706 DISORIENTATION 34 0.0009
707 MOUTH ULCERATION 18 0.0009
708 ARTHRALGIA 355 0.0009
709 ABASIA 21 0.0008
710 HAEMOGLOBIN DECREASED 87 0.0008
711 LIMB INJURY 23 0.0008
712 UNEVALUABLE EVENT 64 0.0008
713 MUSCULOSKELETAL CHEST PAIN 13 0.0008
714 SKIN DISORDER 28 0.0008
715 DIABETIC KETOACIDOSIS 20 0.0008
716 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
717 BACK INJURY 9 0.0008
718 DYSARTHRIA 31 0.0008
719 APATHY 12 0.0008
720 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
721 HYPOTHYROIDISM 26 0.0008
722 MUSCULOSKELETAL DISCOMFORT 14 0.0008
723 SENSORY DISTURBANCE 13 0.0008
724 ACTIVITIES OF DAILY LIVING IMPAIRED 16 0.0008
725 DELIRIUM 28 0.0008
726 GASTROINTESTINAL DISORDER 72 0.0008
727 CORONARY ARTERY OCCLUSION 11 0.0008
728 BLOOD POTASSIUM DECREASED 24 0.0008
729 OEDEMA PERIPHERAL 96 0.0008
730 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
731 BLINDNESS 32 0.0008
732 LIMB DISCOMFORT 24 0.0008
733 SUICIDE ATTEMPT 47 0.0008
734 HIATUS HERNIA 10 0.0008
735 ACUTE MYELOID LEUKAEMIA 12 0.0008
736 AMNESIA 50 0.0008
737 MENTAL STATUS CHANGES 21 0.0008
738 OEDEMA 41 0.0008
739 PLEURAL EFFUSION 46 0.0008
740 CONJUNCTIVITIS 14 0.0008
741 ULCER 12 0.0008
742 FATIGUE 587 0.0008
743 RASH ERYTHEMATOUS 36 0.0008
744 ABSCESS 12 0.0008
745 MYOCARDIAL INFARCTION 131 0.0008
746 COGNITIVE DISORDER 35 0.0007
747 RASH MACULAR 26 0.0007
748 PRODUCT PHYSICAL ISSUE 15 0.0007
749 PANIC ATTACK 27 0.0007
750 FAECES DISCOLOURED 16 0.0007
751 SKIN ULCER 19 0.0007
752 PALLOR 20 0.0007
753 METASTASES TO BONE 12 0.0007
754 DIARRHOEA 469 0.0007
755 VERTIGO 44 0.0007
756 MYELOSUPPRESSION 26 0.0007
757 NEOPLASM MALIGNANT 48 0.0007
758 RESPIRATORY FAILURE 52 0.0007
759 LYMPHOPENIA 10 0.0007
760 HYPOPHAGIA 18 0.0007
761 DRUG INEFFECTIVE 921 0.0007
762 NECK PAIN 39 0.0007
763 DEATH 601 0.0007
764 SLEEP DISORDER 49 0.0007
765 PRURITUS GENERALISED 15 0.0007
766 WHITE BLOOD CELL COUNT DECREASED 75 0.0007
767 PHOTOPHOBIA 13 0.0007
768 DYSPNOEA EXERTIONAL 26 0.0007
769 INFLAMMATION 35 0.0007
770 ADVERSE EVENT 62 0.0007
771 INSOMNIA 178 0.0007
772 ANGINA PECTORIS 19 0.0007
773 NAUSEA 524 0.0007
774 GAIT INABILITY 22 0.0007
775 URTICARIA 110 0.0007
776 ANGIOEDEMA 29 0.0007
777 EPILEPSY 20 0.0007
778 PAIN IN EXTREMITY 192 0.0007
779 TENDONITIS 10 0.0006
780 HEADACHE 404 0.0006
781 CONFUSIONAL STATE 104 0.0006
782 EJECTION FRACTION DECREASED 10 0.0006
783 SCAR 11 0.0006
784 CARDIAC ARREST 52 0.0006
785 APHASIA 19 0.0006
786 PRODUCTIVE COUGH 30 0.0006
787 HYPOAESTHESIA 94 0.0006
788 METASTASES TO LIVER 11 0.0006
789 POST PROCEDURAL COMPLICATION 12 0.0006
790 DEPRESSED MOOD 33 0.0006
791 CARDIO-RESPIRATORY ARREST 26 0.0006
792 INTERSTITIAL LUNG DISEASE 30 0.0006
793 FEBRILE NEUTROPENIA 41 0.0006
794 PALPITATIONS 72 0.0006
795 GYNAECOMASTIA 19 0.0006
796 CEREBRAL INFARCTION 15 0.0006
797 NEUTROPHIL COUNT DECREASED 25 0.0006
798 CONVULSION 35 0.0006
799 HALLUCINATION 46 0.0006
800 THERAPEUTIC RESPONSE DECREASED 37 0.0006
801 DEMENTIA 17 0.0006
802 DISABILITY 12 0.0006
803 ROAD TRAFFIC ACCIDENT 25 0.0006
804 PRODUCT DISPENSING ERROR 13 0.0006
805 CHILLS 69 0.0006
806 CHEST PAIN 109 0.0006
807 RENAL CANCER 28 0.0006
808 TINNITUS 27 0.0006
809 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
810 HYPOGLYCAEMIA 28 0.0006
811 C-REACTIVE PROTEIN INCREASED 21 0.0006
812 SLEEP APNOEA SYNDROME 11 0.0006
813 TOXICITY TO VARIOUS AGENTS 97 0.0006
814 LETHARGY 33 0.0006
815 DERMATITIS 12 0.0006
816 BRADYCARDIA 30 0.0006
817 PRODUCT USE IN UNAPPROVED INDICATION 140 0.0006
818 GASTROINTESTINAL HAEMORRHAGE 47 0.0006
819 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 40 0.0006
820 INTENTIONAL DOSE OMISSION 16 0.0006
821 SYNOVITIS 10 0.0006
822 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
823 ABDOMINAL PAIN LOWER 14 0.0006
824 MUSCULOSKELETAL PAIN 29 0.0006
825 BACK DISORDER 9 0.0006
826 TACHYCARDIA 49 0.0006
827 PRODUCT ADMINISTRATION ERROR 11 0.0005
828 HOSPITALISATION 83 0.0005
829 CARDIAC FAILURE 43 0.0005
830 DRUG ABUSE 44 0.0005
831 COLITIS 20 0.0005
832 INJURY 37 0.0005
833 PNEUMONIA 170 0.0005
834 URINARY TRACT INFECTION 88 0.0005
835 VIRAL INFECTION 17 0.0005
836 SWELLING FACE 33 0.0005
837 ABDOMINAL PAIN UPPER 104 0.0005
838 MEDICATION ERROR 28 0.0005
839 HAEMOPTYSIS 14 0.0005
840 OFF LABEL USE 439 0.0005
841 DISTURBANCE IN ATTENTION 27 0.0005
842 MOVEMENT DISORDER 16 0.0005
843 DYSPEPSIA 49 0.0005
844 GASTROOESOPHAGEAL REFLUX DISEASE 40 0.0005
845 MALAISE 217 0.0005
846 HYPERSENSITIVITY 91 0.0005
847 HAEMATOCHEZIA 27 0.0005
848 HYPOTENSION 98 0.0005
849 HERPES ZOSTER 28 0.0005
850 THERAPY CESSATION 25 0.0005
851 COUGH 135 0.0005
852 URINARY RETENTION 16 0.0005
853 DISCOMFORT 29 0.0005
854 CARDIAC FAILURE CONGESTIVE 38 0.0005
855 CARDIOVASCULAR DISORDER 12 0.0005
856 URINARY INCONTINENCE 14 0.0005
857 DYSPNOEA 267 0.0005
858 FALL 156 0.0005
859 RESPIRATORY DISORDER 14 0.0005
860 AGITATION 34 0.0005
861 SKIN EXFOLIATION 39 0.0005
862 SEDATION 12 0.0005
863 RED BLOOD CELL COUNT DECREASED 13 0.0005
864 ABNORMAL BEHAVIOUR 18 0.0005
865 WEIGHT INCREASED 101 0.0005
866 HAEMORRHAGE 47 0.0004
867 ORAL PAIN 10 0.0004
868 PARAESTHESIA 70 0.0004
869 ARRHYTHMIA 21 0.0004
870 CEREBROVASCULAR ACCIDENT 75 0.0004
871 SEIZURE 51 0.0004
872 DIZZINESS 220 0.0004
873 AGEUSIA 11 0.0004
874 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 23 0.0004
875 SYNCOPE 44 0.0004
876 ACCIDENTAL OVERDOSE 16 0.0004
877 ADVERSE DRUG REACTION 39 0.0004
878 PRURITUS 165 0.0004
879 FLATULENCE 24 0.0004
880 VISION BLURRED 58 0.0004
881 MUCOSAL INFLAMMATION 11 0.0004
882 UPPER RESPIRATORY TRACT INFECTION 19 0.0004
883 SOMNOLENCE 82 0.0004
884 CARDIAC DISORDER 38 0.0004
885 BRONCHITIS 30 0.0004
886 BALANCE DISORDER 35 0.0004
887 DEEP VEIN THROMBOSIS 26 0.0004
888 RECTAL HAEMORRHAGE 17 0.0004
889 EYE DISORDER 13 0.0004
890 BLISTER 22 0.0004
891 DRUG ADMINISTRATION ERROR 12 0.0004
892 DYSGEUSIA 29 0.0004
893 EYE PAIN 22 0.0004
894 ANAPHYLACTIC SHOCK 10 0.0004
895 MEMORY IMPAIRMENT 53 0.0004
896 HYPERSOMNIA 11 0.0004
897 JOINT STIFFNESS 10 0.0004
898 GASTRIC DISORDER 13 0.0004
899 CELLULITIS 19 0.0004
900 MOOD SWINGS 12 0.0004
901 HYPOACUSIS 16 0.0004
902 IRRITABILITY 22 0.0004
903 SPEECH DISORDER 19 0.0004
904 CRYING 13 0.0004
905 OVERDOSE 77 0.0004
906 PRODUCT USE ISSUE 67 0.0004
907 INTENTIONAL PRODUCT MISUSE 31 0.0004
908 LOSS OF CONSCIOUSNESS 45 0.0004
909 INJECTION SITE REACTION 24 0.0003
910 DISEASE PROGRESSION 41 0.0003
911 ERYTHEMA 71 0.0003
912 LUNG NEOPLASM MALIGNANT 14 0.0003
913 IMPAIRED HEALING 11 0.0003
914 DRY MOUTH 27 0.0003
915 SWELLING 31 0.0003
916 CONSTIPATION 72 0.0003
917 HEART RATE INCREASED 32 0.0003
918 EPISTAXIS 24 0.0003
919 SWOLLEN TONGUE 10 0.0003
920 DYSKINESIA 13 0.0003
921 MUSCULOSKELETAL STIFFNESS 28 0.0003
922 INTESTINAL OBSTRUCTION 12 0.0003
923 ALOPECIA 62 0.0003
924 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
925 HYPERHIDROSIS 40 0.0003
926 FEELING HOT 19 0.0003
927 PLASMA CELL MYELOMA 12 0.0003
928 SKIN DISCOLOURATION 14 0.0003
929 INFLUENZA LIKE ILLNESS 25 0.0003
930 RESTLESSNESS 11 0.0003
931 MUSCLE SPASMS 55 0.0003
932 VAGINAL HAEMORRHAGE 13 0.0003
933 BLOOD GLUCOSE INCREASED 56 0.0003
934 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
935 SURGERY 17 0.0003
936 UNDERDOSE 21 0.0003
937 PERIPHERAL SWELLING 44 0.0003
938 ILL-DEFINED DISORDER 17 0.0003
939 AGGRESSION 14 0.0003
940 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
941 FLUID RETENTION 14 0.0003
942 THROMBOSIS 22 0.0003
943 BLOOD PRESSURE DECREASED 18 0.0003
944 COLITIS ULCERATIVE 12 0.0003
945 ECZEMA 14 0.0003
946 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
947 JOINT SWELLING 32 0.0003
948 INTENTIONAL OVERDOSE 17 0.0003
949 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
950 CHEST DISCOMFORT 27 0.0003
951 DRUG DOSE OMISSION 42 0.0003
952 NO ADVERSE EVENT 45 0.0002
953 ATRIAL FIBRILLATION 24 0.0002
954 PULMONARY OEDEMA 11 0.0002
955 SINUSITIS 25 0.0002
956 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
957 INFLUENZA 26 0.0002
958 STOMATITIS 14 0.0002
959 MIGRAINE 22 0.0002
960 NERVOUSNESS 12 0.0002
961 BLOOD GLUCOSE DECREASED 11 0.0002
962 BLOOD PRESSURE INCREASED 35 0.0002
963 BURNING SENSATION 16 0.0002
964 CATARACT 13 0.0002
965 VISUAL IMPAIRMENT 27 0.0002
966 COMPLETED SUICIDE 18 0.0002
967 PROSTATE CANCER 17 0.0002
968 CONTUSION 19 0.0002
969 HOT FLUSH 14 0.0002
970 OROPHARYNGEAL PAIN 17 0.0002
971 COVID-19 32 0.0002
972 PSORIASIS 23 0.0002
973 FEELING ABNORMAL 42 0.0002
974 ILLNESS 18 0.0002
975 PRODUCT SUBSTITUTION ISSUE 10 0.0002
976 BREAST CANCER 16 0.0002
977 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 31 0.0002
979 ASTHMA 17 0.0002
980 DRY SKIN 20 0.0001
981 ACNE 11 0.0001
982 NASOPHARYNGITIS 26 0.0001
983 FLUSHING 13 0.0001
984 PRODUCT STORAGE ERROR 11 0.0001
985 PRODUCT QUALITY ISSUE 16 0.0001
986 DRUG WITHDRAWAL SYNDROME 10 0.0001
987 PULMONARY EMBOLISM 10 0.0001
988 INCORRECT DOSE ADMINISTERED 21 0.0001
989 PRODUCT DOSE OMISSION ISSUE 22 0.0001
990 INJECTION SITE PAIN 19 0.0001
991 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001